The effect of epibatidine on spontaneous and evoked neurotransmitter release in the mouse and guinea pig isolated vas deferens

British Journal of Pharmacology

Volumn 150, Issue 7, 2007, Pages 906-912

  Williams, D J ^a   Brain, K L ^a   Cunnane, T C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Electrophysiology; Epibatidine; Guinea pig; Intracellular recording; Mouse; Neurotransmission; Nicotinic; Prejunctional; Sympathetic; Vas deferens

Indexed keywords

ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CYCLOPENTOLATE; EPIBATIDINE; PRAZOSIN; TETRODOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; EXCITATORY JUNCTION POTENTIAL; GUINEA PIG; INTRACELLULAR RECORDING; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE; STATISTICAL SIGNIFICANCE; VAS DEFERENS;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; GUINEA PIGS; ISOMETRIC CONTRACTION; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED BALB C; NICOTINIC AGONISTS; PYRIDINES; RECEPTORS, NICOTINIC; VAS DEFERENS;

EID: 34047196556     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707183     Document Type: Article

References (31)

1. Alkondon M, Pereira EF, Barbosa CT, Albuquerque EX (1997). Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J Pharmacol Exp Ther 283: 1396-1411.
2. Badio B, Daly JW (1994). Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol 45: 563-569.
3. Berridge MJ, Lipp P, Bootman MD (2000). The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11-21.
4. Brain KL, Bennett MR (1997). Calcium in sympathetic varicosities of mouse vas deferens during facilitation, augmentation and auto-inhibition. J Physiol 502 (Part 3): 521-536.
5. Brain KL, Trout SJ, Jackson VM, Dass N, Cunnane TC (2001). Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores. Neuroscience 106: 395-403.
6. Burnstock G, Holman ME (1964). An electrophysiological investigation of the actions of some autonomic blocking drugs on transmission in the guinea-pig vas deferens. Br J Pharmacol Chemother 23: 600-612.
7. Büyükafsar K, Levent A, Ark M (2003). Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens. Br J Pharmacol 140: 743-749.
8. Covernton PO, Lester RA (2002). Prolonged stimulation of presynaptic nicotinic acetylcholine receptors in the rat interpeduncular nucleus has differential effects on transmitter release. Int J Dev Neurosci 20: 247-258.
9. Cuprian AM, Solanki P, Jackson MV, Cunnane TC (2005). Cholinergic innervation of the mouse isolated vas deferens. Br J Pharmacol 146: 927-934.
10. Dani JA, Radcliffe KA, Pidoplichko VI (2000). Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas. Eur J Pharmacol 393: 31-38.
11. Fenster CP, Rains MF, Noerager B, Quick MW, Lester RA (1997). Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17: 5747-5759.
12. 2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 35: 1-8.
13. Gerzanich V, Peng X, Wang F, Wells G, Anand R, Fletcher S et al. (1995). Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol 48: 774-782.
14. Grady SR, Marks MJ, Collins AC (1994). Desensitization of nicotine-stimulated [3 H]dopamine release from mouse striatal synaptosomes. J Neurochem 62: 1390-1398.
15. Haass M, Kubler W (1997). Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 10: 657-665.
16. Holman ME, Taylor GS, Tomita T (1977). Some properties of the smooth muscle of mouse vas deferens. J Physiol 266: 751-764.
17. Jayasundar S, Vohra MM (1977). Mechanism of nicotine-induced release of noradrenaline from adrenergic nerve endings. Br J Pharmacol 61: 183-188.
18. Kaschube M, Zetler G (1989). Noradrenergic, purinergic, and cholinergic transmission in the mouse vas deferens: influence of field-stimulation parameters, reserpinization, 6-hydroxydopamine and 4-aminopyridine. J Neural Transm 76: 39-53.
19. Lu Y, Marks MJ, Collins AC (1999). Desensitization of nicotinic agonist-induced [3 H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. J Pharmacol Exp Ther 291: 1127-1134.
20. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA (1997). Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390: 401-404.
21. Quick MW, Lester RA (2002). Desensitization of neuronal nicotinic receptors. J Neurobiol 53: 457-478.
22. Radcliffe KA, Dani JA (1998). Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 18: 7075-7083.
23. Rose JE, Westman EC, Behm FM, Johnson MP, Goldberg JS (1999). Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacol Biochem Behav 62: 165-172.
24. Sjöstrand N (1965). The adrenergic innervation of the vas deferens and accessory male genital organs. Acta Physiol Scand 257: 1-82.
25. Somlyo AP, Somlyo AV (2003). Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358.
26. Todorov L, Windisch K, Shersen H, Lajtha A, Papasova M, Vizi ES (1991). Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea-pig. Br J Pharmacol 102: 186-190.
27. von Kügelgen I, Starke K (1991a). Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 12: 319-324.
28. von Kügelgen I, Starke K (1991b). Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol 344: 419-429.
29. Webster RG, Brain KL, Wilson RH, Grem JL, Vincent A (2005). Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. Br J Pharmacol 146: 1027-1039.
30. Wonnacott S (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci 20: 92-98.
31. Zhu PJ, Chiappinelli VA (2002). Nicotinic receptors mediate increased GABA release in brain through a tetrodotoxin-insensitive mechanism during prolonged exposure to nicotine. Neuroscience 115: 137-144.